Chronic diseases such as cancer and cardiovascular conditions are driving a significant share of hospital spending in the Philippines, with a small group of patients accounting for a disproportionate portion of healthcare costs, according to a new study.
The report by the Philippine Institute for Development Studies (PIDS) analyzed 5.8 million inpatient claims from 2023 submitted to the Philippine Health Insurance Corp. (PhilHealth).
The study provides a detailed snapshot of hospital utilization and spending patterns across the archipelago.
The distribution of PhilHealth reimbursements reveals a heavy concentration of costs among high-cost users.
Defined as patients in the top 5th percentile, these individuals account for 20.1 percent—roughly a fifth—of all reimbursements.
Nearly 65 percent of these high-cost cases are linked to noncommunicable diseases (NCDs), including heart disease and cancer.
These chronic illnesses often require repeated hospitalizations, specialized treatment and long-term management.
The findings are detailed in the study, “Measuring Hospital Performance in the Philippines: Evidence on Quality, Efficiency, and Equity from Social Health Insurance Claims,” authored by researchers from the PIDS Health Economics and Finance Program.
In 2023, more than 250,000 high-cost users generated about P14 billion pesos in reimbursements. This represented about a fifth of PhilHealth’s total inpatient payouts.
“A small subset of patients, often those with complex or chronic conditions, consumes a disproportionate share of resources,” the authors said.
“This potentially crowds out coverage for the broader population’s needs if not managed effectively,” they said.
The researchers noted that the concentration of spending reflects the healthcare needs of patients with severe, long-term conditions rather than an “excessive use” of services.
The study highlighted several trends regarding where and how these funds are spent.
High-cost cases are largely managed in Level 3 hospitals, which provide advanced care. Nearly half of all reimbursements are concentrated in these facilities.
The National Capital Region accounts for about 25 percent of reimbursements for high-cost patients, highlighting the centralization of specialized services in Metro Manila.
Adults and elderly patients make up the majority of high-cost cases, underscoring the growing burden of chronic diseases as the Philippine population ages.
The researchers said that strengthening prevention, early detection and long-term disease management could reduce resource-intensive hospitalizations and ease pressure on the healthcare system.
The analysis underscores the need for targeted payment reforms to reduce catastrophic health spending for Filipinos while improving cost control across the national insurance system.
